Valuation: Amgen Inc.

Market Cap 195B 171B 158B 147B 277B 18,498B 282B 1,895B 735B 9,117B 734B 718B 31,779B P/E 2026 *
23.6x
P/E 2027 * 21.7x
Enterprise Value 237B 208B 192B 179B 337B 22,446B 343B 2,299B 892B 11,063B 891B 871B 38,560B EV / Sales 2026 *
6.28x
EV / Sales 2027 * 5.98x
Free-Float
99.78%
Yield 2026 *
2.79%
Yield 2027 * 2.94%
1 day+0.44%
1 week+5.05%
Current month+7.52%
1 month+7.52%
3 months+3.83%
6 months+9.86%
Current year+10.64%
1 week 346
Extreme 346
363.11
1 month 322.3
Extreme 322.3
363.11
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 67 2019-12-31
Chief Operating Officer 59 2016-07-24
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%+5.05%+30.67%+63.74% 195B
-2.48%+8.83%+54.68%+158.23% 1,097B
-1.76%+9.81%+66.64%+54.77% 622B
-1.05%+9.40%+38.03%+88.88% 449B
+0.83%+6.34%+29.51%+24.01% 334B
-1.38%+6.09%+37.91%+25.49% 294B
+0.30%+5.24%+31.61%+42.02% 286B
-0.10%+4.88%-28.09%-41.02% 213B
+0.01%+1.18%+14.16%+66.21% 157B
-1.19%-3.99%-0.45%-33.33% 139B
Average -0.04%+5.74%+27.46%+44.90% 378.56B
Weighted average by Cap. -0.07%+8.26%+39.81%+75.15%

Financials

2026 *2027 *
Net sales 37.76B 33.06B 30.52B 28.48B 53.6B 3,574B 54.58B 366B 142B 1,762B 142B 139B 6,140B 38.71B 33.89B 31.29B 29.2B 54.95B 3,664B 55.95B 375B 146B 1,806B 145B 142B 6,295B
Net income 8.23B 7.21B 6.65B 6.21B 11.68B 779B 11.9B 79.81B 30.96B 384B 30.93B 30.23B 1,338B 8.86B 7.76B 7.16B 6.69B 12.58B 839B 12.81B 85.95B 33.34B 414B 33.31B 32.56B 1,441B
Net Debt 41.7B 36.51B 33.71B 31.45B 59.2B 3,947B 60.28B 404B 157B 1,946B 157B 153B 6,781B 36.06B 31.57B 29.14B 27.19B 51.18B 3,413B 52.11B 350B 136B 1,682B 135B 132B 5,863B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-06-30 $362.12 +0.44% 2,237,858
26-06-29 $360.55 +0.62% 2,461,887
26-06-26 $358.33 +1.56% 3,610,561
26-06-25 $352.82 +0.40% 2,341,847
26-06-24 $351.43 +1.27% 2,391,890
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
362.12USD
Average target price
354.76USD
Spread / Average Target
-2.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock